The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year




Market Cap


About KingMed Diagnostics

Guangzhou Kingmed Diagnostics Group, dba KingMed Diagnostics (金域医学), is a third-party medical laboratory group. Founded in 1994, KingMed Diagnostics is mainly engaged in 4 major businesses including medical testing, clinical trials, food and hygiene testing, and scientific research service.

KingMed Diagnostics Headquarter Location

Guangzhou, Guangdong,


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest KingMed Diagnostics News

Diagnostic Labs Market is expected to garner US$ 514.28 Bn by 2028 at 8.3% CAGR - Exclusive Report by The Insight Partners

Jul 18, 2022

Global Diagnostic Labs Market: Competitive Landscape and Key Developments Eurofins Scientific, Laboratory Corporation of America Holdings, Exact Sciences Laboratories LLC, SYNLAB International GmbH, Dasa Labs, KingMed Diagnostics, BioReference, Sonic Healthcare Limited, and Healius Limited are the leading companies in the global diagnostic labs market. The market is anticipated to flourish with the development of new innovative products by market players. Inquiry Before Purchase: In August 2021, eMed, a telehealth company, announced a collaboration with Quest Diagnostics, the world's leading provider of diagnostic information services, to bring clinician-guided rapid antigen testing for COVID-19 employers to seek faster, safer environment by decreasing the risk of COVID-19 exposure at workplaces. In February 2021, GRAIL, Inc., a healthcare company, announced an agreement with Quest Diagnostics, a leading provider of diagnostic information service, offering support for GRAIL's multicancer early detection blood test. North America is the largest market for diagnostic labs, with the US holding the largest share of the regional market, followed by Canada and Mexico. The diagnostic labs market in the US is expected to grow in the coming years with the increasing adoption of technological advancements, and rising research and development activities are projected to accelerate the growth of the US diagnostic labs market. Further, the American Association for Clinical Chemistry (AACC) reports that in the US, approximately 13 billion laboratory tests are performed annually in more than 200,000 clinical laboratories. Have a question? Speak to Research Analyst: Additionally, diagnostic laboratory services comprise only 2.3% of US healthcare expenditure and 2% of medicare expenditure. Moreover, nearly 25% of the US patient care quality indicators for adults are included in laboratory tests. Quality indicators are standardized, evidence-based measures of healthcare quality that can be used readily by hospitals serving inpatient administrative data for tracking and measuring clinical performance and outcomes. Such quality indicators play a vital role in ensuring high-quality, cost-effective clinical care by informing laboratory medicine professionals to obtain objective scientific data and deliver an interpretation of the results of the US adults. Such factors mentioned above stimulate the growth of diagnostic labs in the US during the forecast period. Increasing Prevalence of Chronic Diseases to Influence Diagnostic Labs Market According to the key facts on Noncommunicable Diseases (NCDs) released by the World Health Organization (WHO) in April 2021, chronic diseases kill approximately 41 million people each year, accounting for 71% of all deaths worldwide. The increase in chronic diseases also fuels the need for healthcare systems. Clinical diagnostics have thus proven beneficial in the states with prevalent chronic diseases and are valuable in disease prevention, detection, and treatment. Clinical diagnostics help identify early warning signs and individual risk factors and create new opportunities for prevention and early intervention. Therefore, the rising incidence of chronic diseases is expected to propel the overall market further. It is estimated that the US will experience significant growth due to its high burden of chronic diseases, which requires support from clinical laboratory services for efficient treatment and patient care. For example, according to the National Center for Biotechnology Information (NCBI), 45.0% of the US population, i.e., 133 million people, suffered from at least one chronic disease in 2018. According to the Centers for Disease Control and Prevention (CDC), four out of 10 adults in the US have two or more chronic diseases, and six out of 10 adults have one chronic disease. Chronic diseases such as cancer, heart disease, and diabetes are the leading causes of death and disability in the US, which has led to higher demand for better treatment with efficient management, further driving the market in the US. Avail Lucrative DISCOUNTS on “Diagnostic Labs Market” Research Study: Global Diagnostic Labs Market: Segmental Overview Based on lab type, the global diagnostic labs market is segmented into single/independent laboratories, hospital-based labs, physician office labs, and others. In 2022, the hospital-based labs segment is estimated to hold the largest market share. Based on testing services, the global diagnostic labs market is segmented into physiological function testing, general and clinical testing, esoteric testing, specialized testing, non-invasive prenatal testing, COVID-19 testing, and others. The physiological function testing segment is estimated to hold the largest market share in 2022. Based on the revenue source, the global diagnostic labs market is segmented into endoscopy, X-ray, CT, ECG, MRI, Echo, and Others. The healthcare plan operators and insurers segment is estimated to hold the largest share of the market in 2022 and is anticipated to register the highest CAGR during the forecast period. Directly Purchase Premium Copy of Diagnostic Labs Market Growth Report at: Browse Adjoining Reports:   Point of Care Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy and Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Hematology Testing Products, and Other POC Products), Prescription Mode (Prescription-Based Testing and OTC Testing), and End User (Professional Diagnostic Centers, Home Care, Research Laboratories, and Others), and Geography Esoteric Testing Market to 2025 - Global Analysis and Forecasts by Technology (Chemiluminescence Immunoassay, Real-Time PCR, Flow Cytometry, Mass Spectrometry, Enzyme-Linked Immunosorbent Assay and Others), Test Type (Infectious Diseases Testing, Oncology Testing, Genetic Testing, Neurology Testing, Endocrinology Testing, Toxicology Testing and Others), End User (Hospital Laboratories, and Independent & Reference Laboratories) and Geography Diagnostic Imaging Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Modality (X-Ray, CT, Endoscopy, Ultrasound, MRI, Nuclear Imaging, Mammography, and Others), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Obstetrics and Gynecology, and Others), and End User (Hospital and Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others) Diagnostic Electrocardiograph Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service (Product, Software and Service); Lead Type (12-lead, 5-lead, 3-lead, 6-lead, Single-lead, Other Lead Types); End-User (Hospitals, Clinics and Cardiac Centers, Ambulatory Surgical Centers, Other End Users) and Geography Independent Clinical Laboratories Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Clinical Trials Testing, Diagnostics Testing Services, Others); End User (Pharmaceutical and Biotechnology Companies, Diagnostics and Research Laboratories, Contract Manufacturers), and Geography COVID-19 Serology Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Neutralization Tests, Chemiluminescent Immunoassay (CLIA), Enzyme-linked Immunosorbent Assays (ELISAs), Rapid Diagnostic Test (RDT)); Application (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs) Covid-19 Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Test Type (Molecular Tests, Serology Tests); Application (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs) Clostridium Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Clostridium Difficile, Clostridium Perfringens, Clostridium Botulinum, Clostridium Tetani, and Clostridium Sordellii); Technology (Immunoassays, and Molecular Diagnostics); End Use (Hospitals, Government Diagnostic Laboratories, Independent Laboratories, and Others), and Geography About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact Us: If you have any queries about this report or if you would like further information, please contact us: Contact Person: Sameer Joshi

KingMed Diagnostics Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

KingMed Diagnostics Rank

  • When was KingMed Diagnostics founded?

    KingMed Diagnostics was founded in 2014.

  • Where is KingMed Diagnostics's headquarters?

    KingMed Diagnostics's headquarters is located at Guangzhou.

  • What is KingMed Diagnostics's latest funding round?

    KingMed Diagnostics's latest funding round is PIPE - II.

  • Who are the investors of KingMed Diagnostics?

    Investors of KingMed Diagnostics include CITIC Securities, Green Pine Capital Partners, Boyu Capital, Legend Star, CDBI Partners and 5 more.

  • Who are KingMed Diagnostics's competitors?

    Competitors of KingMed Diagnostics include KingCreate Biotechnology.

You May Also Like

KingCreate Biotechnology

KingCreate Biotechnology operates as a manufacturer engaged in the research and development, production, sales and service of in vitro diagnostic equipment.

Ximedica Logo

Ximedica is a development firm that focuses on medical products; developing medical devices, combination products and consumer healthcare products.On September 7th, 2021, Ximedica was acquired by Veranex. Terms of the transaction were not disclosed.


Avioq is a medical diagnostic company established to develop and market immunodiagnostic products. Avioq also provides contract development and manufacturing services in the company's FDA licensed, ISO 13485 facilities.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.